Tobias Maetzig

3.1k citations
47 papers · 2.1k indexed · h-index 22
Topics
Virus-based gene therapy research (26 papers)CRISPR and Genetic Engineering (26 papers)RNA Interference and Gene Delivery (22 papers)

In The Last Decade

Tobias Maetzig

46 papers receiving 2.0k citations

Peers

Tobias Maetzig
Comparison fields: 5 of 81
  • Molecular Biology 1.7k
  • Genetics 1.2k
  • Oncology 489
  • Immunology 175
  • Hematology 133
Replace Daniela Cesana with:
Daniela Cesana Italy
Samuel L. Murphy United States
Steven J. Howe United Kingdom
Melanie Galla Germany
Fabian Gross France
Jennifer E. Adair United States
Salima Hacein‐Bey France
Fabrizio Benedicenti Italy
Gregory M. Podsakoff United States
Kathryn L. Parsley United Kingdom
Tobias Maetzig relative to Daniela Cesana Italy Daniela Cesana's profile →
Citations per field
00.5×1.5×1.8×
Daniela Cesana · 1×
Citations per year

Countries citing papers authored by Tobias Maetzig

Since Specialization
Citations

This map shows the geographic impact of Tobias Maetzig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tobias Maetzig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tobias Maetzig more than expected).

Fields of papers citing papers by Tobias Maetzig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tobias Maetzig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tobias Maetzig. The network helps show where Tobias Maetzig may publish in the future.

Co-authorship network of co-authors of Tobias Maetzig

This figure shows the co-authorship network connecting the top 25 collaborators of Tobias Maetzig. A scholar is included among the top collaborators of Tobias Maetzig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tobias Maetzig. Tobias Maetzig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 19
3 22
4 6
5 13
6 22
7 15
8 20
9 10
10 5
11 42
12 7
13 46
14 206
15 13
16 53
17 74
18 38
19 289
20 215

About Tobias Maetzig

Tobias Maetzig is a scholar working on Genetics, Hematology and Virology, having authored 47 papers that have together received 2.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (26 papers), CRISPR and Genetic Engineering (26 papers) and RNA Interference and Gene Delivery (22 papers). The work is most often cited by research in Genetics (1.2k citations), Molecular Biology (1.7k citations) and Virology (90 citations). Tobias Maetzig has collaborated with scholars based in Germany, United States and Canada. Frequent co-authors include Axel Schambach, Melanie Galla, Christopher Baum, Daniela Zychlinski, Ute Modlich, Martijn H. Brugman, Christopher Baum, Johannes Kuehle, Rainer Loew and Tobias Cantz. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026